CDMRP Prostate Cancer Research Program:Exploration – Hypothesis Development Award

The Exploration – Hypothesis Development Award supports the exploration of highly innovative, untested, potentially high-gain concepts, theories, paradigms, and/or methods that address an important problem relevant to one or more of the FY24 PCRP Overarching Challenges: 

• Improve quality of life to enhance outcomes and overall health and wellness for those impacted by prostate cancer
• Develop treatments or improve upon existing therapies to improve outcomes for patients with lethal prostate cancer
• Advance health equity and reduce disparities in prostate cancer
• Define the biology of prostate cancer progression to lethal prostate cancer to reduce death

It is expected that fifteen (15) awards will be granted. 

Funding: $150,000 total  
Duration: 2 years

Research Authority due date: 13.6.24

Pre application (required) due date: 21.6.24

Full proposal due date: 12.7.24